Skip to main content

Table 1 Clinical features of the 258 patients with multiple lung cancers

From: The characteristics and prognosis of different disease patterns of multiple primary lung cancers categorized according to the 8th edition lung cancer staging system

Patient characteristics

Results

Age (y), mean ± SD

60.0 ± 8.0

BMI, mean ± SD

24.9 ± 6.1

Male, n (%)

139 (53.9%)

Smoker, n (%)

121 (46.9%)

Drinking history, n (%)

62 (24.0%)

Personal history of neoplasia, n (%)

24 (9.3%)

Family history of neoplasia, n (%)

64 (24.8%)

Family history of lung cancer, n (%)

39 (15.1%)

Past medical history, n (%)

89 (34.5%)

Presented symptoms before the first surgery, n (%)

106 (41.1%)

Prime symptoms before the first surgery, n (%)

 
 

Cough

66 (25.6%)

 

Expectoration

40 (15.5%)

 

Bloody sputum

20 (7.8%)

 

Chest pain

14 (5.4%)

 

Fever

7 (2.7%)

 

Hemoptysis

4 (1.6%)

Number of resected tumors, n (%)

 
 

2

208 (80.6%)

 

3

37 (14.3%)

 

4

10 (3.9%)

 

5

2 (0.8%)

 

6

1 (0.4%)

Times the patient underwent surgery, n (%)

 
 

1

136 (52.7%)

 

2

121 (46.9%)

 

3

1 (0.4%)

Types of multiple cancers (simultaneous/metachronous)

 
 

Simultaneous lung cancers

206 (79.8%)

 

Metachronous lung cancers

52 (20.2%)

Types of surgery (thoracotomy/VATS)

 
 

VATS

100 (38.8%)

 

Thoracotomy

120 (46.5%)

 

Thoracotomy and VATS

38 (14.7%)

Type(s) of resection of multiple lesions

 
 

Lobectomy + sublobar resection

127 (49.2%)

 

Lobectomy + lobectomy

54 (20.9%)

 

Sublobar resection + sublobar resection

36 (14.0%)

 

Lobectomy

31 (12.0%)

 

Pneumonectomy

10 (3.9%)

Relationship of the locations of multiple lesions

 
 

Ipsilateral tumors

159 (61.6%)

 

Bilateral tumors

99 (38.4%)

Pathological type

 
 

Adenocarcinoma

183 (70.9%)

 

Squamous cell carcinoma

37 (14.3%)

 

Adenocarcinoma and squamous cell carcinoma

14 (5.4%)

 

Adenosine carcinoma and adenocarcinoma

11 (4.3%)

 

Adenocarcinoma and large cell carcinoma

3 (1.2%)

 

Adenocarcinoma and sarcomatoid carcinoma

2 (0.8%)

 

Small cell carcinoma

2 (0.8%)

 

Squamous cell carcinoma and large cell carcinoma

1 (0.4%)

 

Squamous cell carcinoma and pleomorphic carcinoma

1 (0.4%)

 

Squamous cell carcinoma and carcinoid

1 (0.4%)

 

Squamous cell carcinoma and small cell carcinoma

1 (0.4%)

 

Adenocarcinoma and carcinoid

1 (0.4%)

 

Adenocarcinoma and inflammatory myofibroblastoma

1 (0.4%)

Location of lesions

 
 

Right upper lobe

187 (32.1%)

 

Left upper lobe

126 (21.6%)

 

Right inferior lobe

111 (19.0%)

 

Left inferior lobe

89 (15.3%)

 

Right middle lobe

70 (12.0%)

Types of multiple cancers (according to 8th TNM stage)

 
 

Multifocal GG/L nodules

139 (53.9%)

 

Second primary lung cancer

63 (24.4%)

 

Multifocal lung cancers with relationship not sure

47 (18.2%)

 

Separate tumor nodule

9 (3.5%)

With lung nodules not resected*

 
 

Yes

42 (16.3%)

 

No

216 (83.7%)

TNM stage

 
 

I

151 (58.5%)

 

II

23 (89.1%)

 

III

37 (14.3%)

 

Not sure

47 (18.2%)

  1. *With lung nodules not resected: the number of patients with unresected nodules in the lungs